ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,321.655
-0.49%
Brent Oil
81.955
-0.21%
Bitcoin
66,479.50
-0.24%
Pepperstone
Advertisement
Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. 10x Genomics Inc (TXG)

  7. 10x Genomics Inc (TXG) News

10x Genomics (TXG)

10x Genomics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TXG
DateTimeSourceHeadlineSymbolCompany
13/06/202421:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
06/06/202421:13Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:TXG10x Genomics Inc
31/05/202421:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
29/05/202421:05PR Newswire (US)10x Genomics Launches 5,000-Plex Gene Panel for XeniumNASDAQ:TXG10x Genomics Inc
24/05/202400:54Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
24/05/202400:53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
24/05/202400:52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
22/05/202421:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
22/05/202421:23Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
22/05/202421:17Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
02/05/202421:05PR Newswire (US)10x Genomics to Present at the BofA Securities 2024 Healthcare ConferenceNASDAQ:TXG10x Genomics Inc
30/04/202421:05PR Newswire (US)10x Genomics Reports First Quarter 2024 Financial ResultsNASDAQ:TXG10x Genomics Inc
10/04/202421:05PR Newswire (US)10x Genomics to Report First Quarter 2024 Financial Results on April 30, 2024NASDAQ:TXG10x Genomics Inc
26/03/202413:00PR Newswire (US)10x Genomics Commercially Launches Visium HD Spatial Gene Expression AssayNASDAQ:TXG10x Genomics Inc
21/03/202420:05PR Newswire (US)10x Genomics Expands Xenium Menu with Multi-Modal Cell Segmentation Kit and Immuno-Oncology Gene PanelNASDAQ:TXG10x Genomics Inc
13/03/202420:05PR Newswire (US)10x Genomics Begins Commercial Shipments of Chromium GEM-X ProductsNASDAQ:TXG10x Genomics Inc
06/03/202421:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
04/03/202423:40Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
26/02/202421:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
26/02/202421:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
26/02/202421:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
23/02/202400:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
23/02/202400:06Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
22/02/202423:59Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:TXG10x Genomics Inc
20/02/202421:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TXG10x Genomics Inc
20/02/202421:05PR Newswire (US)10x Genomics to Present at the 44th Annual TD Cowen Health Care ConferenceNASDAQ:TXG10x Genomics Inc
15/02/202422:33Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TXG10x Genomics Inc
15/02/202422:16Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:TXG10x Genomics Inc
15/02/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TXG10x Genomics Inc
15/02/202421:05PR Newswire (US)10x Genomics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Outlook for 2024NASDAQ:TXG10x Genomics Inc
 Showing the most relevant articles for your search:NASDAQ:TXG

Your Recent History

LSE
GKP
Gulf Keystone Petroleum
LSE
PANR
Pantheon Resources
LSE
LLOY
Lloyds Banking
LSE
SVE
Starvest
LSE
TW.
Taylor Wimpey
LSE
IQG
Iqgeo
LSE
CPL
LSE
HZM
Horizonte Minerals
LSE
KMK
Kromek
LSE
HE1
Helium One Global
LSE
SQZ
Serica Energy
LSE
XPF
Xp Factory
LSE
ESO
Epe Special Opportunities
LSE
RBD
Reabold Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved